출판 : MarketsandMarkets(마켓츠앤드마켓츠)출판년월 : 2022년03월
제품(실습 장치(3D 매핑, 기록), 절제 카테터(냉동 절제, RF), 진단 카테터(종래, 고도, 초음파)), 디스플레이(AF, AVNRT, WPW), 최종 사용자(병원, ASC) – 2027년까지의 세계 예측
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) – Global Forecasts to 2027
페이지수 | 284 |
도표수 | 224 |
구성 | 영문조사보고서 |
가격 |
The global electrophysiology market is projected to reach USD 11.6 billion by 2027 from USD 6.8 billion in 2021, at a CAGR of 9.4% during the forecast period of 2022 to 2027.
세계 전기생리학 시장은 2022년에서 2027년까지의 예측 기간 동안 9.4%의 CAGR로 2021년 68억 달러에서 2027년 116억 달러에 이를 것으로 예상됩니다.
An electrophysiology (EP) test is conducted to study the electrical activities and electrical pathways of the patient’s heart to diagnose and treat complex cardiac diseases. It enables electrophysiologists to understand the cause of heart rhythm disturbances and suggest the required treatment. Electrophysiology (EP) is defined as the heart’s electrical system that is being studied to analyze and diagnose its electrical activities. Cardiac electrophysiology studies the phenomena by recording the electrical activities of the heart using an invasive catheter. This study helps in assessing complex Arrhythmias or heart rhythm disorders.
The growth of the global electrophysiology market can be attributed to factors such as technological advancements; new entrants in the market; growing investments, funds, and grants; and an increased incidence of target diseases and procedures. Emerging markets are also expected to offer high growth opportunities for players operating in this market.
According to the WHO, CVD is the leading cause of death around the world. Major factors contributing to the rising prevalence of CVD and strokes include family history, ethnicity, and age. According to the American Heart Association, by 2030, about 41.4% of the US adults will have hypertension (an increase of 8.4% from 2012). The organization also estimates that the global cost of CVD will reach USD 1,044 billion by 2030 from USD 863 billion in 2010. In 2016, ~17.9 million people died of CVD worldwide. It is estimated that, by 2030, this number will increase to 23.6 million (Source: WHO).
AF is the most common arrhythmia diagnosed in clinical practices, affecting over 886,000 new people each year in Europe. By 2030, the number of people with AF is expected to increase by up to 70% of the population; by 2050, Europe is expected to have the highest number of patients with AF (Source: 2018 Report on Burden of Atrial Fibrillation). In the US, AF affected between about 2.7 million to 6.1 million people in 2012; this is estimated to rise to 12.1 million by 2030 (Source: CDC). According to a study published in the Medical Journal of Australia in August 2015, the number of AF patients aged above 55 years in Australia was 328,562 in June 2014 and is estimated to reach over 600,000 cases by 2034. The rising incidence of these diseases will correspondingly drive the demand for EP procedures, which makes it a primary growth driver for the electrophysiology market. For instance, the global ablation procedure numbers are predicted to grow from 973,220 in 2017 to 1,455,000 per year by 2022; within this category, complex ablations (AF and VT) is expected to increase by 13.5% annually from 440,629 in 2017 to 830,390 in 2022 (Source: BioSig Technologies, Annual Report, 2019).
However, factors such as the high cost of electrophysiology products, inadequate reimbursement, unfavorable healthcare reforms in the US, cost-intensive requirement for clinical data for new product launches, and the availability of alternative technologies are expected to restrain the growth of this market in the coming years. The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market. The growth of the market is also expected to slow temporarily during the forecast period due to the COVID-19 pandemic.
“Electrophysiology Laboratory Device segment accounted for the largest share of global electrophysiology market in 2021”
On the basis of product, the global electrophysiology market is broadly classified into EP diagnostic catheters, EP ablation catheters, EP laboratory devices, access devices, and other products.
EP laboratory devices market is segmented into 3D mapping systems, EP recording systems, RF ablation systems, intra-cardiac echocardiography (ICE) ultrasound imaging systems, EP X-ray systems, and other electrophysiology laboratory devices (MRI systems and EP remote magnetic and robotic navigation systems).
The EP laboratory devices segment commanded the largest share of 57.0% of the electrophysiology market in 2021. This segment is estimated to grow at a CAGR of 10.6% during the forecast period.
The large share of this segment can be attributed to the increasing focus of market players on the launch of technologically advanced 3D mapping systems, increasing public-private funding for the development of novel electrophysiology recording systems, the rising number of RF ablation procedures, the cost-effectiveness of RF ablation procedures as compared to other ablation techniques, and increasing availability of these products in major markets.
“Hospitals and cardiac centres segment accounted for the largest market share of the electrophysiology market based on end user in 2021”
On the basis of the end user segment, the electrophysiology market is segmented into hospitals & cardiac centers and ambulatory surgery centers. The hospitals & cardiac centers segment holds the largest share of the market (92.53%) in 2021. The large share of this end user segment can primarily be attributed to the presence of big cath labs and electrophysiology labs in hospitals, a rising prevalence of CVDs, and an increased number of ablation procedures.
The hospital & cardiac centers segment includes both government & private hospitals and cardiac centers that provide treatment to patients with cardiac diseases. Almost all electrophysiology procedures are carried out in the electrophysiology (EP) laboratory or catheterization laboratory (cath lab) of hospitals or cardiac centers. The number of cardiac centers providing treatment to patients with heart conditions is growing rapidly across the world. For instance, in June 2016, Health Sciences North (Canada) and a team of cardiologists in Greater Sudbury (Canada) joined forces to launch a new one-stop center for cardiac care. In October 2016, US-based Kare Partners Group launched a specialized heart care center in Chandigarh, India. Such launches are expected to drive the demand for electrophysiology devices.
“Atrial Fibrillation segment accounted for the largest market share of the electrophysiology market based on indication type in 2021”
On the basis of indication type, the electrophysiology market is segmented into atrial fibrillation, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, atrial flutter, and other indications. The increasing prevalence of atrial fibrillation, the growing number of ablation procedures related to atrial fibrillation, rapid growth in the aging population globally, and the development of advanced electrophysiology products for the early diagnosis of atrial fibrillation are expected to drive the growth of this market segment in the coming years.
The atrial fibrillation market accounted for the largest share of the electrophysiology market, by indication, in 2021. The atrial flutter segment is estimated to account for the second-largest share of the global electrophysiology market in 2021.
About 5.3 million people in the US were reportedly suffering from atrial fibrillation in 2019 (Source: American Heart Association). By 2050, atrial fibrillation is expected to affect approximately 12 million people in the US. According to the paper published in EP Europace, a journal of the European Society of Cardiology (ESC), around 7.6 million people over 65 in the EU region had atrial fibrillation in 2016, and this will increase by 89% to 14.4 million by 2060. This growth in the prevalence of atrial fibrillation is expected to result in a significant increase in the number of atrial fibrillation ablation procedures conducted.
Owing to the increasing prevalence of AFib, many key players are undertaking studies to showcase the advantages of catheter ablation over antiarrhythmic drugs (AADs). For instance, in November 2019, Biosense Webster released a new Atrial Fibrillation Management Report, which highlights that catheter ablation is almost ten times more effective at delaying Atrial Fibrillation progression than drug therapy.
“The APAC market, by region, to register highest growth rate in the forecast period”
On the basis of region, the Electrophysiology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.
China and India are expected to account for the highest growth rate. Changing lifestyles and eating habits, increasing stress, and rising habitual smoking & drinking in these countries have resulted in growing health-related problems such as obesity, heart disease, and other chronic diseases. Factors such as large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, increasing demand for advanced technologies, the growing emphasis of prominent players on emerging markets, and less stringent regulations are also fueling the demand for electrophysiology devices in this region.
However, the high cost of advanced products, inadequate infrastructural capabilities to comply with the latest cardiac resynchronization technologies, and a lack of awareness about health-related issues are expected to hamper the growth of this market. Many end users in this regional segment have controlled budgets and opt for low-cost products, which is another major factor limiting the market growth.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
• By Designation: C-level–34%, Director-level–35%, and Others–31%
• By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%
Prominent players in the electrophysiology market include Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), and Acutus Medical, Inc. (US).
Research Coverage
This report studies the electrophysiology market based on product type, indication type, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the electrophysiology market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the electrophysiology market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the electrophysiology market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY USED
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 26)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.1.2 Indicative list of secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. – 37)
4 PREMIUM INSIGHTS (Page No. – 41)
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND INDICATION
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2021 VS. 2027
4.5 GEOGRAPHICAL SNAPSHOT OF ELECTROPHYSIOLOGY MARKET
5 MARKET OVERVIEW (Page No. – 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High rate of technological advancements
5.2.1.1.1 Increased use of non-invasive cardiac mapping
5.2.1.1.2 Increased use of improved intracardiac ablation systems
5.2.1.1.3 Increased use of MRI guided ablation procedures
5.2.1.1.4 Growing level of ultrasound guidance in the EP Lab
5.2.1.2 Rising number of new entrants in the market
5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology
5.2.1.4 Increasing incidence of target diseases and procedures
5.2.2 RESTRAINTS
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement process
5.2.2.2 Unfavorable healthcare reforms in the US
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Rising number of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Increasing rate of reusing and reprocessing of devices
5.2.4.2 Lack of skilled and experienced electrophysiologists
5.3 REGULATORY LANDSCAPE
5.3.1 NORTH AMERICA
5.3.1.1 US
5.3.1.2 Canada
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.3.1 India
5.3.3.2 China
5.3.3.3 Japan
5.4 COVID-19 IMPACT
5.5 REIMBURSEMENT SCENARIO
5.6 PATENT ANALYSIS
5.6.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY
5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.8 PRICING TREND ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 ECOSYSTEM LANDSCAPE
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT (Page No. – 73)
6.1 INTRODUCTION
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES
6.2.1 3D MAPPING SYSTEMS
6.2.1.1 Development of alternative technologies to hinder market growth
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS
6.2.2.1 Increasing public-private funding to drive market growth
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS
6.2.3.1 Rising number of RF ablation procedures to drive market growth
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS
6.2.4.1 Advantages of ICE ultrasound imaging systems to drive market growth
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS
6.2.5.1 Magnetic navigation systems to hamper market growth
6.2.6 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS
6.2.6.1 Favorable reimbursement scenario to drive market growth
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
6.3.1.1 Significant therapeutic advantages to drive market growth
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS
6.3.2.1 Technological advancements in radiofrequency ablation catheters to drive the market
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS
6.3.3.1 Advantages of Microwave Ablation Systems over RF Ablation Catheters to drive market growth
6.3.4 LASER ABLATION SYSTEMS
6.3.4.1 Technologically advanced products to drive market growth
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1.1 Increasing demand in emerging markets to support market growth
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.2.1 Advantages of Advanced Electrophysiology Diagnostic Catheters over conventional EP diagnostic catheters to drive market growth
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems to drive market growth
6.5 ACCESS DEVICES
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS TO DRIVE MARKET GROWTH
6.6 OTHER PRODUCTS
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION TYPE (Page No. – 99)
7.1 INTRODUCTION
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER TO DRIVE MARKET GROWTH
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT TO DRIVE MARKET GROWTH
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WOLFF-PARKINSON-WHITE SYNDROME TO DRIVE MARKET GROWTH
7.6 OTHER INDICATIONS
8 ELECTROPHYSIOLOGY MARKET, BY END USER (Page No. – 106)
8.1 INTRODUCTION
8.2 HOSPITALS & CARDIAC CENTERS
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END USER SEGMENT
8.3 AMBULATORY SURGERY CENTERS
8.3.1 INCREASING NUMBER OF AMBULATORY SURGICAL CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
9 ELECTROPHYSIOLOGY MARKET, BY REGION (Page No. – 110)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 Technological advancements to drive market growth
9.2.2 CANADA
9.2.2.1 Growing government funding for research to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth
9.3.2 UK
9.3.2.1 Growing geriatric population to drive market growth
9.3.3 FRANCE
9.3.3.1 Increasing incidence of heart failure to support market growth
9.3.4 ITALY
9.3.4.1 Rising incidence of CVDs to drive electrophysiology devices adoption
9.3.5 SPAIN
9.3.5.1 Growing number of cardiac ablation procedures to drive market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Favorable reimbursement scenario to support market growth
9.4.2 CHINA
9.4.2.1 Growing geriatric population to drive market growth
9.4.3 INDIA
9.4.3.1 Increasing healthcare initiatives by government to drive market growth
9.4.4 AUSTRALIA
9.4.4.1 Increasing target disease burden to support market growth
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives to drive market growth
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities to drive market growth
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE (Page No. – 179)
10.1 INTRODUCTION
10.2 REVENUE SHARE ANALYSIS
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
10.6 COMPETITIVE BENCHMARKING
10.7 COMPETITIVE SCENARIO (2018–2021)
10.7.1 PRODUCT LAUNCHES
10.7.2 APPROVALS
10.7.3 DEALS
11 COMPANY PROFILES (Page No. – 196)
11.1 KEY PLAYERS
11.1.1 ABBOTT
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weakness and competItive treats
11.1.1.4.4 COVID-19 impact
11.1.2 MEDTRONIC
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.4 MnM view
11.1.2.4.1 Right to Win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weakness and competitive treats
11.1.2.4.4 COVID-19 impact
11.1.3 BOSTON SCIENTIFIC CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.4 KONINKLIJKE PHILIPS N.V.
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.5 GE HEALTHCARE
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.6 SIEMENS HEALTHINEERS
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.7 STEREOTAXIS, INC.
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.8 MERIT MEDICAL SYSTEMS
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 ATRICURE INC.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 APN HEALTH, LLC
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 OSYPKA MEDICAL
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 JAPAN LIFELINE CO., LTD.
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.13 JOHNSON & JOHNSON
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.4 MnM view
11.1.13.4.1 Right to win
11.1.13.4.2 Strategic choices
11.1.13.4.3 Weakness and competItive treats
11.1.13.4.4 COVID-19 impact
11.1.14 BIOTRONIK
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.15 MICROPORT SCIENTIFIC CORPORATION
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.16 ACUTUS MEDICAL, INC.
11.1.16.1 Business overview
11.1.16.2 Products offered
11.1.16.3 Recent developments
11.2 OTHER PLAYERS
11.2.1 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
11.2.2 CATHRX LTD.
11.2.3 COOK MEDICAL
11.2.4 CATHVISION APS
11.2.5 TZ MEDICAL
11.2.6 TELEFLEX INCORPORATED
11.2.7 IMRICOR
11.2.8 CARDIOFOCUS
11.2.9 SCHWARZER CARDIOTEK GMBH
11.2.10 KARDIUM
11.2.11 EP SOLUTIONS SA
11.2.12 BIOSIG TECHNOLOGIES, INC. (BSGM)
11.2.13 COREMAP
11.2.14 EPMAP SYSTEM GMBH
12 APPENDIX (Page No. – 272)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (181 Tables)
TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 8 CHINA (NPMA): CLASSIFICATION OF MEDICAL DEVICES
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES BY PMDA
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR 2022 (PHYSICIAN)
TABLE 11 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL OUTPATIENT)
TABLE 12 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL INPATIENT)
TABLE 13 TOP 10 PATENT OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
TABLE 14 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, BY DEVICE NAME, 2020 (USD)
TABLE 15 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 16 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 17 EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 18 EP LABORATORY DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 19 EP LABORATORY DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 20 EP LABORATORY DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 21 3D MAPPING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 22 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 23 RF ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 24 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 25 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 26 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 27 EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 28 EP ABLATION CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 29 EP ABLATION CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 30 EP ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 31 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 32 RF ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 33 MWA SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 34 LASER ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 35 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 36 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 37 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 38 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 39 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 40 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 41 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 42 ACCESS DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 43 ACCESS DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 44 ACCESS DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 45 OTHER PRODUCTS MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 46 OTHER PRODUCTS MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 47 OTHER PRODUCTS MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 48 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 49 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2019–2027 (USD MILLION)
TABLE 50 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2019–2027 (USD MILLION)
TABLE 51 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2019–2027 (USD MILLION)
TABLE 52 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2019–2027 (USD MILLION)
TABLE 53 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2027 (USD MILLION)
TABLE 54 ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 55 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2019–2027 (USD MILLION)
TABLE 56 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 (USD MILLION)
TABLE 57 ELECTROPHYSIOLOGY MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 58 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 59 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 65 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES
TABLE 66 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 67 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 68 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 69 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 70 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 71 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 72 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 73 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 74 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 75 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 76 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 77 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 78 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 79 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 80 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 81 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 82 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 83 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 84 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 85 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 86 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 87 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 88 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 89 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 90 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 91 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 92 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 93 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 94 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 95 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 96 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 97 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 98 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 99 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 100 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 101 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 102 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 103 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 104 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 105 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 106 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 107 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 108 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 109 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 110 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 111 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 113 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 114 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 115 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 116 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 117 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 118 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 119 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 120 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 121 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 122 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 123 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 124 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 125 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 126 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 127 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 128 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 129 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 130 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 131 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 132 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 133 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 134 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 135 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 136 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 137 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 138 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 139 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 140 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 141 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 142 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 143 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 144 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 145 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 146 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 147 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 148 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 149 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 150 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 151 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 152 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 153 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 154 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 155 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 156 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 157 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 158 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 159 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 160 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 161 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION)
TABLE 162 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 163 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION
TABLE 164 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET
TABLE 165 COMPANY FOOTPRINT ANALYSIS IN ELECTROPHYSIOLOGY MARKET
TABLE 166 ABBOTT: BUSINESS OVERVIEW
TABLE 167 MEDTRONIC: BUSINESS OVERVIEW
TABLE 168 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
TABLE 169 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 170 GE HEALTHCARE: BUSINESS OVERVIEW
TABLE 171 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
TABLE 172 STEREOTAXIS, INC.: BUSINESS OVERVIEW
TABLE 173 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
TABLE 174 ATRICURE, INC.: BUSINESS OVERVIEW
TABLE 175 APN HEALTH, LLC: BUSINESS OVERVIEW
TABLE 176 OSYPKA MEDICAL: BUSINESS OVERVIEW
TABLE 177 JAPAN LIFELINE CO., LTD.: BUSINESS OVERVIEW
TABLE 178 JOHNSON & JOHNSON: BUSINESS OVERVIEW
TABLE 179 BIOTRONIK: BUSINESS OVERVIEW
TABLE 180 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
TABLE 181 ACUTUS MEDICAL, INC.: BUSINESS OVERVIEW
LIST OF FIGURES (44 Figures)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
FIGURE 10 ASIA PACIFIC MARKET TO HAVE HIGHEST CAGR DURING FORECAST PERIOD (2022-2027)
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2021 BY INDICATION
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 IN PRODUCT SEGMENT
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 15 BY END USER 2021 VS 2027
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2022-2027)
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 NUMBER OF PATENTS ISSUED (2011 -2021)
FIGURE 19 TOP 10 PATENTS OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
FIGURE 20 TOP 10 PATENT APPLICANTS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021)
FIGURE 21 PATENTS FOR ELECTROPHYSIOLOGY, BY JURISDICTION (JANUARY 2011 TO DECEMBER 2021)
FIGURE 22 VALUE CHAIN OF ELECTROPHYSIOLOGY MARKET
FIGURE 23 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM LANDSCAPE
FIGURE 24 GEOGRAPHIC SNAPSHOT OF ELECTROPHYSIOLOGY MARKET
FIGURE 25 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN ELECTROPHYSIOLOGY MARKET, 2018–2021
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET
FIGURE 29 ELECTROPHYSIOLOGY MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 30 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
FIGURE 31 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2020)
FIGURE 32 ABBOTT: COMPANY SNAPSHOT (2020)
FIGURE 33 MEDTRONIC: COMPANY SNAPSHOT (2021)
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2020)
FIGURE 39 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020)
FIGURE 40 ATRICURE, INC.: COMPANY SNAPSHOT (2020)
FIGURE 41 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT (2020)
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
FIGURE 43 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 44 ACUTUS MEDICAL INC.: COMPANY SNAPSHOT (2020)